Back to Home
Home >> Molecular Biotechnology >>Detection of Genetic Disorders by Using Molecular Biotechnology Techniques
Back to Home

Detection of Genetic Disorders by Using Molecular Biotechnology Techniques - There are several hundred recognized genetic diseases in man which result from single recessive mutations. In some cases, a protein product that is defective or absent has been identified but in many others the nature of the mutation is unknown. For many of these genetic diseases there is no definite treatment and their prevention is the current strategy in many countries.

An essential prerequisite for prenatal diagnosis is the availability of foetal DNA. Foetal cells can be obtained by amniocentesis but this method is not entirely satisfactory for it cannot be carried out early in pregnancy. An alternative approach is to obtain foetal DNA from biopsies of trophoblastic villi in the first trimester of pregnancy.

DNA amplification is done without purification of the cellular DNA with PCR. Of all genetic diseases, the inherited haemoglobin disorder has been the most extensively studied at the DNA level. In what follows, Haemoglobinnopathies will be taken as examples. Their antenatal diognosis by recombinant DNA techniques has served as a prototype for other genetic disorders. Clinically the most important Haemoglobinnopathies are sickle cell anaemia and the thalassaemia site in genomic DNA.

This can be used as all Marker for the presence or absence of the defect. Digesting the mutated and normal DNA with the restriction enzyme and performing Southern-blot hybridization with a cloned β-globulin DNA probe can therefore detect the mutation.

Such an approach is applicable only to those disorders where there is an alteration in a restriction site or where a major deletion or rearrangement alters the restriction pattern.